
Palisade Bio Inc
NASDAQ:PALI

Intrinsic Value
The intrinsic value of one
PALI
stock under the Base Case scenario is
2.5185
USD.
Compared to the current market price of 0.7014 USD,
Palisade Bio Inc
is
Undervalued by 72%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Palisade Bio Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Palisade Bio Inc
Balance Sheet Decomposition
Palisade Bio Inc
Current Assets | 10.5m |
Cash & Short-Term Investments | 9.8m |
Receivables | 24k |
Other Current Assets | 649k |
Non-Current Assets | 386k |
PP&E | 87k |
Other Non-Current Assets | 299k |
Free Cash Flow Analysis
Palisade Bio Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Palisade Bio Inc
Revenue
|
0
USD
|
Operating Expenses
|
-14.9m
USD
|
Operating Income
|
-14.9m
USD
|
Other Expenses
|
421k
USD
|
Net Income
|
-14.4m
USD
|
PALI Profitability Score
Profitability Due Diligence
Palisade Bio Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Score
Palisade Bio Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
PALI Solvency Score
Solvency Due Diligence
Palisade Bio Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Score
Palisade Bio Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PALI Price Targets Summary
Palisade Bio Inc
Dividends
Current shareholder yield for PALI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PALI
stock under the Base Case scenario is
2.5185
USD.
Compared to the current market price of 0.7014 USD,
Palisade Bio Inc
is
Undervalued by 72%.